Fennec Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Fennec Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Fennec Pharmaceuticals Inc
Rating: 1.60225
Author: Trendlyne DVM scores

about

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

7.66 -0.14 (-1.79%)

63.68% Gain from 52W Low

56,680

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

20.5 / 100

Technically Neutral

43.6 / 100

1Yr Price target upside is 98%

6 analysts

Fennec Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Fennec Pharma Inc Live Stock Price Today, Share Analysis and Chart

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

63.68% Gain from 52W Low

SWOT Analysis

Fennec Pharma Inc Live Price Chart